Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ASP1650 |
Trade Name | |
Synonyms | ASP 1650|ASP-1650|IMAB027|Anti-CLDN6 Mab ASP1650 |
Drug Descriptions |
ASP1650 is a monoclonal antibody that targets Claudin 6 (CLDN6), which potentially induces antibody-dependent cell-mediated cytotoxicity and complement-mediated cytotoxicity against tumor cells expressing CLDN6 (Journal of Clinical Oncology 2020 38:6_suppl, TPS424). |
DrugClasses | CLDN6 Antibody 8 |
CAS Registry Number | NA |
NCIT ID | C114286 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ASP1650 | ASP1650 | 0 | 1 |